MU’s Calinski awarded $10,000 grant for ‘bath salts’ research
FORT WAYNE, Ind. – A $10,000 grant has been awarded to Diane Calinski at Manchester University to research the metabolism of the synthetic drugs commonly referred to as “bath salts.”
Sponsored by the American Association of Colleges of Pharmacy (AACP), the New Investigator Award provides funding for the independent research programs of early-career pharmacy faculty.
Calinski, assistant professor of pharmaceutical sciences and pharmacogenomics at Manchester, was instrumental in establishing the Masters of Pharmacogenomics Program at Manchester. www.manchester.edu/pgx
In addition to the grant for the “Evaluation of Cytochrome P450-Mediated Metabolism of the Synthetic Cathinones,” she will also receive a $1,000 travel award from AACP to present her research findings at its annual meeting in Chicago next summer.
Calinski joined the Pharmacy Program in July 2013. She earned a Ph.D. in pharmacology at the University of Michigan and a bachelor’s degree in biochemistry and molecular biology at Pennsylvania State University.
Synthetic cathinones, which are commonly referred to as “bath salts,” have emerged as popular drugs of abuse within the last decade. The bath salts are similar to the popular club drug Ecstasy (MDMA or Molly). Users typically swallow, snort or inject synthetic cathinones. https://www.drugabuse.gov/publications/drugfacts/synthetic-cathinones-bath-salts
About Manchester University
Manchester University, with campuses in North Manchester and Fort Wayne, Ind., offers more than 60 areas of academic study to nearly 1,600 students in undergraduate programs, a Master of Athletic Training, a Master of Pharmacogenomics and a four-year professional Doctor of Pharmacy. Learn more about the private, northern Indiana school at www.manchester.edu.
February 2018